These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10436902)

  • 1. Further improvements in dose distributions are unlikely to affect cure rates.
    Schulz RJ
    Med Phys; 1999 Jun; 26(6):1007-9. PubMed ID: 10436902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformal treatment planning for interstitial brachytherapy.
    Kovács G; Hebbinghaus D; Dennert P; Kohr P; Wilhelm R; Kimmig B
    Strahlenther Onkol; 1996 Sep; 172(9):469-74. PubMed ID: 8830809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography for radiation treatment planning.
    Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
    Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comments on "Further improvements in dose distributions are unlikely to affect cure rates" [Med. Phys. 26, 1007-1009 (1999)].
    Mohan R; Cardinale R; Hagen M
    Med Phys; 1999 Dec; 26(12):2701-5. PubMed ID: 10619256
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physical brachytherapy planning].
    Muskalla K
    Praxis (Bern 1994); 2001 Sep; 90(36):1532-43. PubMed ID: 11593909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenge of dose escalation in locally advanced unfavourable prostate cancer using HDR brachytherapy.
    Al-Salihi O; Mitra A; Payne H
    Prostate Cancer Prostatic Dis; 2006; 9(4):370-3. PubMed ID: 16832383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric verification of intensity-modulated fields.
    Wang X; Spirou S; LoSasso T; Stein J; Chui CS; Mohan B
    Med Phys; 1996 Mar; 23(3):317-27. PubMed ID: 8815373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical strategies for improving the radiotherapeutic management of prostate cancer.
    Chuba PJ; Forman JD; Ben-Josef E; Hart KH; Porter AT
    Anticancer Res; 1997; 17(3A):1449-54. PubMed ID: 9179182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An atlas-based electron density mapping method for magnetic resonance imaging (MRI)-alone treatment planning and adaptive MRI-based prostate radiation therapy.
    Dowling JA; Lambert J; Parker J; Salvado O; Fripp J; Capp A; Wratten C; Denham JW; Greer PB
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e5-11. PubMed ID: 22330995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
    Das IJ; Cheng CW; Chopra KL; Mitra RK; Srivastava SP; Glatstein E
    J Natl Cancer Inst; 2008 Mar; 100(5):300-7. PubMed ID: 18314476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiation therapy for prostate cancer].
    Sumi M
    Nihon Rinsho; 2005 Feb; 63(2):279-85. PubMed ID: 15714979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple method for dose fusion from multimodality treatment of prostate cancer: brachytherapy to external beam therapy.
    Cao M; Ko SC; Slessinger ED; DesRosiers CM; Johnstone PA; Das IJ
    Brachytherapy; 2011; 10(3):214-20. PubMed ID: 20843747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brachytherapy for clinically localized prostate cancer: optimal patient selection.
    Kollmeier MA; Zelefsky MJ
    Arch Esp Urol; 2011 Oct; 64(8):847-57. PubMed ID: 22052766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Output factors for fields defined by four independent collimators.
    Murray B; McClean B; Field C
    Med Phys; 1995 Mar; 22(3):285-90. PubMed ID: 7596317
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment on "Reporting and analyzing dose distributions: a concept of equivalent uniform dose" [Med. Phys. 24, 103-109 (1997)].
    McGary JE; Grant W; Woo SY; Butler EB
    Med Phys; 1997 Aug; 24(8):1323-4; author reply 1325-7. PubMed ID: 9284258
    [No Abstract]   [Full Text] [Related]  

  • 16. Isotope choice and the effect of edema on prostate brachytherapy dosimetry.
    Butler WM; Merrick GS; Dorsey AT; Lief JH
    Med Phys; 2000 May; 27(5):1067-75. PubMed ID: 10841411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
    Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
    Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shaping of photon beams from electron linear accelerators in radiation therapy.
    Izewska J
    Med Phys; 1993; 20(1):171-7. PubMed ID: 8455496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent developments in radiation oncology-integrating radiation physics and molecular radiobiology advances into clinical radiotherapy practice and beyond].
    Teh BS; Paulino A; Butler EB
    Ai Zheng; 2008 Aug; 27(8):885-93. PubMed ID: 18710628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dosimetric comparison of 169Yb versus 192Ir for HDR prostate brachytherapy.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Milickovic N; Giannouli S; Baltas D
    Med Phys; 2005 Dec; 32(12):3832-42. PubMed ID: 16475783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.